UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 505

Sortiert nach

Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant

American journal of transplantation, 2012-05, Vol.12 (5), p.1157-1167

2012

Link zum Volltext

Verfügbarkeit prüfen

Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor‐Specific Antibody Development and Improve Outcomes

American journal of transplantation, 2013-12, Vol.13 (12), p.3114-3122

2013

Link zum Volltext

Verfügbarkeit prüfen

Rejection: An Integrated Response

American journal of transplantation, 2013-09, Vol.13 (9), p.2239-2240

2013

Link zum Volltext

Verfügbarkeit prüfen

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody

American journal of transplantation, 2015-11, Vol.15 (11), p.2921-2930

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibodies Beyond HLA

American journal of transplantation, 2013-04, Vol.13 (4), p.831-832

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of C1q Status and Titer of De Novo Donor‐Specific Antibodies as Predictors of Allograft Survival

American journal of transplantation, 2017-03, Vol.17 (3), p.703-711

2017

Link zum Volltext

Verfügbarkeit prüfen

Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis

American journal of transplantation, 2007-03, Vol.7 (3), p.512-517

2007

Link zum Volltext

Verfügbarkeit prüfen

Trabecular bone score in kidney transplant recipients

Osteoporosis international, 2016-03, Vol.27 (3), p.1115-1121

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages

Journal of the American Society of Nephrology, 1999-07, Vol.10 (7), p.1582-1589

1999

Link zum Volltext

Verfügbarkeit prüfen

Histological findings in early routine biopsies of stable renal allograft recipients

Transplantation, 1994-01, Vol.57 (2), p.208

1994

Link zum Volltext

Verfügbarkeit prüfen

Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection

Transplantation, 1998-12, Vol.66 (12), p.1673

1998

Link zum Volltext

Verfügbarkeit prüfen

Neointimal and Tubulointerstitial Infiltration by Recipient Mesenchymal Cells in Chronic Renal-Allograft Rejection

The New England journal of medicine, 2001-07, Vol.345 (2), p.93-97

2001

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate

Transplantation, 2003-11, Vol.76 (10), p.1498

2003

Link zum Volltext

Verfügbarkeit prüfen

Does subclinical rejection contribute to chronic rejection in renal transplant patients?

Clinical transplantation, 1999-12, Vol.13 (6), p.441-446

1999

Link zum Volltext

Verfügbarkeit prüfen

Kidney Transplantation Outcomes in Canadian Aboriginals

American journal of transplantation, 2006-08, Vol.6 (8), p.1875-1881

2006

Link zum Volltext

Verfügbarkeit prüfen

Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function

Transplantation, 1998-07, Vol.66 (1), p.38

1998

Link zum Volltext

Verfügbarkeit prüfen

Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema

Transplantation, 1995-02, Vol.59 (4), p.511

1995

Link zum Volltext

Verfügbarkeit prüfen

A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression

American journal of transplantation, 2023-12, Vol.23 (12), p.1882-1892

2023

Link zum Volltext

Verfügbarkeit prüfen

The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patients

Transplantation, 2001-10, Vol.72 (8), p.1453

2001

Link zum Volltext

Verfügbarkeit prüfen

Protocol biopsies in stable renal transplant patients under triple immunosuppression : results at 6 months

Transplantation proceedings, 1994-10, Vol.26 (5), p.2576

1994

Link zum Volltext

Verfügbarkeit prüfen

Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis

Transplantation, 2011-10, Vol.92 (8), p.878

2011

Link zum Volltext

Verfügbarkeit prüfen

HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient

Transplantation, 1989-10, Vol.48 (4), p.695

1989

Link zum Volltext

Verfügbarkeit prüfen

Production of tumor necrosis factor alpha and hemodialysis

Nephron (2015), 1993, Vol.65 (2), p.273

1993

Link zum Volltext

Verfügbarkeit prüfen

Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients

Nephron (2015), 1994, Vol.67 (2), p.190

1994

Link zum Volltext

Verfügbarkeit prüfen

Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts

Transplantation, 2010-08, Vol.90 (4), p.394

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(446)
Mit Volltextzugriff
(390)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(316)
Life Sciences & Biomedicine
(275)
Humans
(246)
Female
(174)
Male
(166)
Biological And Medical Sciences
(148)
Medical Sciences
(132)
Adult
(111)
Middle Aged
(89)
Aged
(77)
Surgery
(66)
Animals
(55)
Transplantation
(53)
Psychiatry
(47)
Psychology. Psychoanalysis. Psychiatry
(41)
Adolescent
(40)
Treatment Outcome
(40)
Physical Sciences
(38)
Pharmacology. Drug Treatments
(37)
Immunology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant

Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor‐Specific Antibody Development and Improve Outcomes

Rejection: An Integrated Response

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody

Antibodies Beyond HLA

Evaluation of C1q Status and Titer of De Novo Donor‐Specific Antibodies as Predictors of Allograft Survival

Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis

Trabecular bone score in kidney transplant recipients

Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages

Histological findings in early routine biopsies of stable renal allograft recipients

Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection

Neointimal and Tubulointerstitial Infiltration by Recipient Mesenchymal Cells in Chronic Renal-Allograft Rejection

Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate

Does subclinical rejection contribute to chronic rejection in renal transplant patients?

Kidney Transplantation Outcomes in Canadian Aboriginals

Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function

Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema

A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression

The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patients

Protocol biopsies in stable renal transplant patients under triple immunosuppression : results at 6 months

Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis

HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient

Production of tumor necrosis factor alpha and hemodialysis

Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients

Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts

Suchergebnisse filtern